Keyphrases
Recombinant Adeno-associated Virus (rAAV)
100%
Human Liver
100%
Liver Tumor
100%
Murine Xenograft Model
100%
Serotype 3
100%
In Vivo Targeting
100%
AAV3
100%
Gene Therapy
50%
Systemic Administration
50%
Vector-based
50%
Recombinant Adeno-associated Virus Vector
50%
Human Liver Cancer
50%
Shikonin
50%
Capsid
25%
Tumor Growth
25%
Threonine
25%
Targeted Delivery
25%
Cancer Treatment
25%
Receptor-ligand Interaction
25%
Cell Surface Receptor
25%
Viral Tropism
25%
Tumorigenesis
25%
Virus Serotype
25%
Chemotherapy Drugs
25%
Mouse Tissue
25%
Transduction Efficiency
25%
Low Efficiency
25%
Liver Damage
25%
Therapeutic Gene
25%
Cancer Xenograft Model
25%
Multifunctional Compounds
25%
Human Liver Cancer Cells
25%
Specific Surface
25%
Medicine and Dentistry
Xenograft
100%
Liver Tumor
100%
Serotype
100%
Liver Cancer
75%
Adeno Associated Virus Vector
50%
Systemic Administration
50%
Shikonin
50%
Gene Therapy
25%
Cancer Therapy
25%
Cancer Cell
25%
Tumor Progression
25%
Receptor
25%
Virus Capsid
25%
Viral Tropism
25%
Adeno-Associated Virus
25%
Carcinogenesis
25%
Liver Injury
25%
Tumor Xenograft
25%
Serine
25%
in Vivo Gene Transfer
25%
Threonine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cancer
100%
Liver Tumor
100%
Adeno Associated Virus Vector
66%
Systemic Administration
66%
Shikonin
66%
Elimination
33%
Chemotherapy
33%
Adeno Associated Virus
33%
Malignant Neoplasm
33%
Receptor
33%
Tumor Growth
33%
Liver Injury
33%
Carcinogenesis
33%
Serine
33%
Threonine
33%
Immunology and Microbiology
Xenograft
100%
Serotype
100%
Adeno Associated Virus Vector
50%
Capsid
25%
Cancer Cell
25%
Adeno Associated Virus
25%
Viral Tropism
25%
in Vivo Gene Transfer
25%
Serine
25%
Threonine
25%
Biochemistry, Genetics and Molecular Biology
Serotype
100%
Adeno Associated Virus Vector
50%
Gene Therapy
25%
Capsid
25%
Cancer Cell
25%
in Vivo Gene Transfer
25%
Adeno Associated Virus
25%
Viral Tropism
25%
Carcinogenesis
25%
Tumor Progression
25%
Serine
25%
Threonine
25%